Inogen Inc (NASDAQ:INGN) — Market Cap & Net Worth
Market Cap & Net Worth: Inogen Inc (INGN)
Inogen Inc (NASDAQ:INGN) has a market capitalization of $138.89 Million ($138.89 Million) as of September 18, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #18033 globally and #4233 in its home market, demonstrating a -2.66% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Inogen Inc's stock price $5.13 by its total outstanding shares 27074516 (27.07 Million). Also see INGN current and non-current assets for a full breakdown of the balance sheet.
Inogen Inc Market Cap History: 2015 to 2026
Inogen Inc's market capitalization history from 2015 to 2026. Data shows change from $1.09 Billion to $138.89 Million (-18.14% CAGR). Also see cash efficiency ratio of Inogen Inc for how efficiently the company converts equity into cash flow.
Index Memberships
Inogen Inc is a constituent of 2 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
NASDAQ Health Care
IXHC
|
$2.67 Trillion | 0.01% | #502 of 976 |
|
NASDAQ Composite
IXIC
|
$41.95 Trillion | 0.00% | #1756 of 3165 |
Weight: Inogen Inc's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Inogen Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Inogen Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Check INGN live share price for real-time trading data and today's change.
Latest Price to Sales (P/S) Ratio
0.52x
Inogen Inc's market cap is 0.52 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $1.82 Billion | $202.83 Million | $20.52 Million | 8.97x | 88.63x |
| 2017 | $3.22 Billion | $249.44 Million | $21.00 Million | 12.93x | 153.51x |
| 2018 | $3.36 Billion | $358.11 Million | $51.84 Million | 9.39x | 64.84x |
| 2019 | $1.85 Billion | $361.94 Million | $20.95 Million | 5.11x | 88.31x |
| 2020 | $1.21 Billion | $308.49 Million | -$5.83 Million | 3.92x | N/A |
| 2021 | $920.53 Million | $358.00 Million | -$6.33 Million | 2.57x | N/A |
| 2022 | $533.64 Million | $377.24 Million | -$83.77 Million | 1.41x | N/A |
| 2023 | $148.64 Million | $315.66 Million | -$102.45 Million | 0.47x | N/A |
| 2024 | $248.27 Million | $335.70 Million | -$35.89 Million | 0.74x | N/A |
| 2025 | $181.94 Million | $348.67 Million | -$22.75 Million | 0.52x | N/A |
Competitor Companies of INGN by Market Capitalization
Companies near Inogen Inc in the global market cap rankings as of September 18, 2026. Review INGN goodwill-adjusted equity ratio to assess the quality of the company's equity after excluding intangible assets.
Key companies related to Inogen Inc by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #126 globally with a market cap of $177.76 Billion USD.
- Medtronic PLC (NYSE:MDT): Ranked #229 globally with a market cap of $109.30 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #235 globally with a market cap of $107.45 Billion USD.
- Medtronic plc (SA:MDTC34): Ranked #241 globally with a market cap of $104.84 Billion USD ( R$534.32 Billion BRL).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #126 | Abbott Laboratories | NYSE:ABT | $177.76 Billion | $102.23 |
| #229 | Medtronic PLC | NYSE:MDT | $109.30 Billion | $92.77 |
| #235 | Stryker Corporation | NYSE:SYK | $107.45 Billion | $280.13 |
| #241 | Medtronic plc | SA:MDTC34 | $104.84 Billion | R$208.39 |
Inogen Inc Historical Marketcap From 2015 to 2026
Between 2015 and today, Inogen Inc's market cap moved from $1.09 Billion to $ 138.89 Million, with a yearly change of -18.14%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $138.89 Million | -23.66% |
| 2025 | $181.94 Million | -26.72% |
| 2024 | $248.27 Million | +67.03% |
| 2023 | $148.64 Million | -72.15% |
| 2022 | $533.64 Million | -42.03% |
| 2021 | $920.53 Million | -23.90% |
| 2020 | $1.21 Billion | -34.61% |
| 2019 | $1.85 Billion | -44.97% |
| 2018 | $3.36 Billion | +4.27% |
| 2017 | $3.22 Billion | +77.28% |
| 2016 | $1.82 Billion | +67.55% |
| 2015 | $1.09 Billion | -- |
End of Day Market Cap According to Different Sources
On Sep 18th, 2026 the market cap of Inogen Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $138.89 Million USD |
| MoneyControl | $138.89 Million USD |
| MarketWatch | $138.89 Million USD |
| marketcap.company | $138.89 Million USD |
| Reuters | $138.89 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Inogen Inc
Inogen, Inc., a medical technology company, develops, manufactures, and markets respiratory health products in the United States and internationally. The company offers portable oxygen concentrators used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. It provides Inogen One and Inogen Rove, an ambulatory solution for long-term oxygen the… Read more